key: cord-0830280-isk3odt1 authors: Oluwasayo Peter, Abodunrin; Onifade, Olayinka Fisayo; Adeboyega, Abayomi Emmanuel title: Therapeutic capability of five active compounds in typical African medicinal plants against main proteases of SARS-CoV-2 by computational approach date: 2022-05-23 journal: Inform Med Unlocked DOI: 10.1016/j.imu.2022.100964 sha: db9b2d930e3a247b1b8a1c24f737683503b54e50 doc_id: 830280 cord_uid: isk3odt1 Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is a pandemic cause of Corona Virus Disease (COVID-19), that has claimed numerous human lives across the globe. Main protease being the active protein of SARS-CoV-2 requires urgent mitigating effect against the spread of the virus. The therapeutic roles of the active compounds present in ten typical African medicinal plants were investigated in this study. Five active compounds Curcuma longa (Curcumin and Bisdethoxy curcumin), Garcinia kola (kolaviron), Zingiber officinale (Gingerol) and Vernonia amygdalina (Artemisinin) were selected and docked against Main protease through receptor grid generation, protein ligand docking, receptor ligand complex pharmacophore and binding free energy. The results obtained revealed Curcumin had the highest binding score of −8.628 kcal/mol while artermisinin presented the least with −4.123 kcal/mol. The outcome of the pharmacokinetic prediction in this study revealed high transport capacity across the gastrointestinal tract and high blood brain barrier permeability for curcumin, bisdemethoxy curcumin, gingerol and artemisinin. The exemption is gingerol with low LD(50) value (250 mg/kg), the LD(50) of all active compounds ranged from 2000 to 4228 mg/kg. Adsorption, distribution, metabolism, excretion and toxicity (ADMET) properties exhibited by all compounds portrayed them as non-hepatotoxic, non-cytotoxic, non-mutagenic and non-carcinogenic. The active compounds exhibited drug-likeness features against Main protease of Covid-19. The Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) as well as Middle East Respiratory Syndrome Coronavirus (MERS-CoV) are member of Coronaviridae family, which affects species ranging from human beings to animals, causing dreadful respiratory diseases [1] . Coronavirus 2019 (COVID-19) emerged from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as a pandemic [2] discovered in Wuhan, Hubei province China, where it was spontaneously transferred from animal source like bats as possible sources to human being [3, 4, 5] . The infection leads to severe respiratory disease after an incubation period of 2 -14 days [6] . The mode of transmission among human beings has been confirmed to be based on contaminated hands, infected surfaces and salivary or airway droplets [7] . The death rate has risen to 5,620,865 with infection cases at 360,578,392 as at 4:37 pm CET, 27 January 2022 [8] . When infecting human cells, SARS-CoV-2 attaches itself with angiotensin converting enzyme 2, ACE2 [9, 10] . ACE2 functions through the decrease blood pressure by lowering the angiotensin 2 [11, 12] . The inflammatory around the lung, through animal research, has been shown as been reversible by improving the expression of ACE2 [13] . Viral proteases enzymes are major drug target; they function essentially, in viral protein maturation through proproteins removal after translation processes in the cytosol of the host cell. SARS-CoV-2 has become medically important coronaviruses because of the resulting health challenges [14, 15] . The viral particles of coronavirus contain 4 major structural proteins: spike, membrane, envelope and nucleocapsid protein. Spike is a vital target for virus entrance into human cells via interaction with the ACE2. Nonstructural proteins possess enzymatic activities like proteases alongside RNA polymerase that redirected its activities. The blocking of the enzymatic regulations is useful when developing antiviral drugs against SARS-CoV2. SARS-CoV-2 is a positive-stranded large RNA genome enveloped betacoronavirus consisting approximately 30 kb of encoded proteins [16, 17, 18] . One of them, Main protease (3 chymotrypsin-like protease) being a cysteine protease, aids maturation cleavage of repeating amino acid units linked by a peptide bond in the process of virus reprodution [19, 20, 21] . Main protease is a homodimer consisting of two promoters: papin-like cyctseine protease (PL pro ) and 3 chymotrypsin-like protease (3CL pro ) alongside three domains; domain I (residue 8-101), domain II (residue 102-184), and domain III (residue 201-303). Domains I and II, are made up of six J o u r n a l P r e -p r o o f -4 -antiparallel β-barrels. An antiparallel globular cluster of five α helices forms domain. Domain III is involved in indirect interaction with substrate crucial for enzymatic activity of proteins through the removal of inactive protease [22] . main protease is an upstream enzyme that involves in the SARS-CoV-2 replication and transcription [23] . The presence of computational model through in-silico screening of potential inhibitory role against the Main protease becomes possible. Applications of plant extracts in medicine have being historically common due to their effectiveness against numerous infections majorly in Africa [24] . Approximately 70% of medications are synthesized directly or indirectly from the active ingredient present in plant extracts nevertheless the high rate of consumption for health improvement is observed in rural environment [25, 24] . Plant extracts are readily available, safe, natural and affordable with limited side effect as compared to synthesized drugs. Plants generally are composed of phytochemical constituents present in different sections ranging from flower, leaf, stem and roots which serves as bioactive compounds responsible for numerous therapeutic role like anti diabetic, anti-inflammatory, antiviral and anti-microbial effects [26] . There are common plants used in Nigeria due to their bioactive compounds and previous infection treatment history. Bitter kola (Garcinia kola) is found majorly in moist forests of Central and Western African countries belonging to the family Guttiferae [27] . The entire parts of the plant are of importance, it is orally applied to alleviate poor health status ranging from erectile dysfunction, cough, gastric problems and high blood pressure. The major biflavonoids present in Garcinia kola is kolaviron responsible for its anti-inflammatory, anti-microbial and wound healing features [28, 29] . Bitter leaf (Vernonia amygdalina) is a small shrub of tropical Africa origin belonging to the daisy family. Vernonia amygdalina is major traditional dish in some region in Nigeria due to its nutritional composition. The presence of artemisinin a bioactive terpenoid present in bitter leaf could be responsible for its usefulness in orthodox medication, being responsible for treating chicken pox, stomach ache, measles, pneumonia and cancer [30] . Ginger (Zingiber officinale) and turmeric (Curcuma longa) are used as cuisines and medicinal spices globally [31, 32] . They are perennial plants of tropical and subtropical Asia Origin. Zingiber officinale contains gingerol as the bioactive compound of phenolic compound and terpeniods while Curcuma longa, curcumin being its bioactive J o u r n a l P r e -p r o o f ingredient of polyphenol making them responsible for various therapeutic functions in aliments like cough, cold, fever, arthritis and cancer [31, 30] . This study was aimed at characterizing the potency of these medicinal plants against SARS-CoV2 protease through molecular docking, pharmacophore modelling and ADMET studies. The crystal structure of Main protease (PDB ID: 6LU7) resolution 2.16 Å was retrieved from Protein Data Bank (PDB) repository. The sample was prepared employing protein preparation wizard panel of Glide [33] to assign bond orders, add hydrogen, create disulfide bonds and, fill missing loops and side chains with prime. Water molecules outside 3.0 Å of the heteroatoms were detached and the structure minimized and optimized employing OPLS3 and PROPKA respectively [34, 33] . Afterwards, the receptor grid file was created to define the binding pocket of the ligands. About sixteen compounds from reviews on phytochemistry and medicinal importance of selected herbs commonly used in treating various infections and ailments in Nigeria [30] . Their structures including that of the standard inhibitor also known as (1s,2s)-2- Acid (K36) were downloaded from the PubChem database were prepared for molecular docking using Ligprep module [35] . Low-energy 3D structures having appropriate chiralities were generated. Possible ionization states for each ligand structure were generated at physiological pH of 7.2 ± 0.2. Also generated were stereoisomers for each ligand by maintaining specified chiralities and varying others. Receptor grid generation permits specifying the size and position of the protein's active site for ligand docking. The scoring grid was specified with respect to the co-crystalized ligand (inhibitors N3) applying the receptor grid generation tool of Schrödinger Maestro 12.5. The van der Waals (vdW) radius scaling factor of nonpolar receptor atoms of 1.0 and partial charge cut-off of 0.25 were applied. Molecular docking studies were undertaken with the generated receptor grid file using Glide tool of Schrödinger Maestro 12.5. The ligands already prepared were docked applying standard precision (SP), setting ligand sampling to flexible, with the ligand sampling set to none (refine only). The vdW radius scaling factor and partial charge cut-off for ligand atoms were 0.80 and 0.15 respectively. A receptor-ligand complex pharmacophore model was developed with PHASE using the first 3 compounds having the top binding affinity towards the target protein. Auto (E-pharmacophore) method was applied; hypothesis set at 7 as the highest number of features being generated, 2.0 as lowest feature to feature distance, 4.0 as lowest feature to feature distance for feature of the same type and donor as vector. The Prime MM-GBSA panel was used to determine the binding free energy for ligand-protein complexes employing the MM-GBSA technology available with Prime [36] . The binding free energy of the protein-ligand complexes was then used to obtain stability of their complexes via Prime MM-GBSA program (Schrödinger suite version 2020-3). Prior to this, the ligands were prepared by ligprep, while the respective proteins were prepared using the protein preparation wizard methods as discussed earlier. The active sites of the proteins were predicted by sitemap. Hence, the compounds were docked with proteins using glide SP docking. With OPLS3 force field selected and VSGB employed as the continuum solvent model, others were set as default 1 . The absorption, distribution, metabolism, excretion and toxicity (ADMET) features of the test compounds were obtained employing in silico integrative model predictions on the SwissADME and PROTOX-II software respectively. The SwissADMET predictions of lipophilicity, solubility, drug-likeness and oral bioavailability of the selected bio active compounds are presented as Table 2 , the pharmacokinetic features as Table 3 while the protox II predicted toxicity profile are as presented in Table 4 . The water solubility, Log S, of curcumin, kolaviron, bisdemethoxy curcumin and -Gingerol were predicted to be moderately soluble The pharmakokinetic prediction in Table 3 portrayed high transport capacity across the gastrointestinal tract and high blood brain barrier (BBB) for curcumin, bisdemethoxy curcumin, gingerol and artemisinin. However, none of the active compounds is substrate to permeability of the glycoprotein (P-gp). Furthermore, bisdemethoxy curcumin, gingerol and artemisinin are predicted to be able to inhibit CYP1A2; curcumin, kolaviron and bisdemethoxy curcumin are predicted to inhibit CYP2C9 and CYP3A4. Moreover, curcumin, kolaviron, bisdemethoxy curcumin gingerol and artemisinin were predicted not to inhibit CYP2C19 and CYP2D6. The Coronaviruses are the virus with positive-polarity RNA genome, making them to depend less on the host cell during replication. The replication occurs in the cytoplasm of the epithelial cells of the respiratory system and the gastrointestinal system [16, 18] . The computational approach of drug design against covid-19 is essential to reduce cost, save time and improve output. NADPH and dTDP-4dehydro-6-deoxy-L-mannose show a significant interaction in silico with the active site of Mpro, with a binding energy of 8.5 and 8.6 kcal/mol, respectively [37] . This study involved five approaches comprising of protein and ligand preparation, receptor grid generation, protein-ligand docking, receptor ligand pharmacophore, binding free energy and pharmacology parameters. In this [38] . Curcumin has been reported to possess antioxidant, antiinflammatory and antibacterial properties [38] . In-silico approach recently found curcumin as safe, being able to also interact in molecular mechanisms with proteins [39] . The docking score obtained for curcumin being higher than the standard ligand K36 may inform its level of interaction with the active site of Main protease of Sars-Cov-2 by forming hydrogen bonds [40, 41] . The protoxll-predicted toxicity profile of curcumin inferred is non-hepatotoxic, non-cytotoxic, non-mutagenic with the LD50 prediction at 2000 mg/kg body weight suggesting that curcumin have good therapeutic properties with drug-likeness for oral drug development [41, 43] . Kolaviron is the active ingredient of Garcinia kola known to possess biflavonoids responsible for its numerous health benefits; the high docking score may account for its interactions with Main protease of covid-19 making it pharmacologically active with numerous pharmacokinetic properties both in-vivo and in-silico [44, 45] . Bisdemethoxy curcumin is a derivative of curcumin, composing of polyphenol and possess anti-cancer and hepatoprotective effect in-vivo [46] . Furthermore, the in-silico ADMET studies have predicted its role as antiviral among many therapeutic functions [47] . Gingerol the active ingredient of Zingiber officinale serves as anti-inflammatory agent; gingerol intreacts with main protease of covid-19 on the carboxyl and hydroxyl ends of the chains which can serve as potential drug target [48] . Artemisinin the active component of Vernonia amygdalina and an active anti-malaria component [49, 4, 50] , though had the least docking score, interact with SARS-CoV-2 Main protease on Glu 166 and Gln 189 making it a potential drug target [51] . These six compounds interacted with important active site amino acids residues of the enzyme; The drug-likeness features which include flexibility, lipophilicity, water solubility, molecular size, plasma protein binding, and saturation of the compound polarity, determine the orally bioavailability of a compound [55, 56] . Curcumin, bisdemethoxy curcumin, gingerol and artemisinin possess high water solubility, vital transport factor within the blood, however kolaviron is poorly soluble. Ethics approval and consent to participate: Not applicable Consent for publication: Not applicable Availability of data and materials: The data that support the findings of this study are available from the corresponding author upon reasonable request. In silico discovery of candidate drugs against Covid-19 Clinical Course and Risk Factors for Mortality of Adult Inpatients with COVID-19 in Wuhan, China: a Retrospective Cohort Study. The Lancet Dynamic basic reproduction number based evaluation for current prevention and control of COVID-19 outbreak in China Enhanced receptor binding of SARS-CoV-2 through networks of hydrogen-bonding and hydrophobic interactions Epidemic trend of corona virus disease 2019 (COVID-19) in mainland China Current Status of Epidemiology, Diagnosis, Therapeutics, and Vaccines for Novel Coronavirus Disease 2019 (COVID-19) Epidemiology Based on Current Evidence WHO (COVID-19) Homepage Repurposing antimalarial to tackle the COVID-19 pandemic Complete genome characterisation of a novel coronavirus associated with severe human respiratory disease in Wuhan, China. bioRxiv Role of the ACE2/Angiotensin 1-7 Axis of the Renin-Angiotensin System in Heart Failure The ACE2/Angiotensin Origin and evolution of pathogenic coronaviruses Responding to Covid-19-a once-in-a-century pandemic? New Engl An overview of their replication and pathogenesis Chemistry and biology of SARS-CoV-2 Genomic characterization and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding Coronavirus genome: prediction of putative functional domains in the nonstructural polyprotein by comparative amino acid sequence analysis The complete sequence (22 kilobases) of murine coronavirus gene1 encoding the putative proteases and RNA polymerase Virus-encoded proteinases and proteolytic processing in the Nidovirales Susceptibility of ferrets, cats, dogs, and other domesticated animals to SARScoronavirus 2 The novel insight of SARS-CoV-2 molecular biology and pathogenesis and therapeutic options Traditional medicinal plants of Nigeria: an overview Screening of crude extracts of six medicinal plants used in South-West Nigerian unorthodox medicine for anti-methicillin resistant Staphylococcus aureus activity A Review on the Phytochemistry, Medicinal Properties and Pharmacological Activities of 15 Selected Myanmar Medicinal Plants Molecules Drought tolerance of Garcinia kola and Garcinia afzelia at the seedling stage Analgesic, anti-inflammatory antipyretic activities of Garcinia hydroxybiflavanonol (GB1) from Garcinia kola Fingerprinting and validation of a LC-DAD method for the analysis of biflavanones in Garcinia kola -based antimalarial improvedtraditional medicines A Review on The Phytochemistry and Medicinal Values of Ten Common Herbs Used In Nigeria Ginger and turmeric ancient spices and modern medicines In Plant genetics and genomics: crops and models 2020-3: Schrödinger Software release 2020 Schrödinger Protein electrostatics and pKa blind predictions; contribution from empirical predictions of internal ionizable residues LigPrep 2020 Schrödinger Deciphering the interactions of compounds from Allium sativum targeted towards identification of novel PTP 1B inhibitors in diabetes treatment: A computational approach SARS-CoV-2 Main Protease Active Site Ligands in the Human Metabolome Antibacterial evaluation, phytochemical screening and ascorbic acid assay of turmeric (Curcuma longa) Molecular docking studies, drug-likeness and in-silico ADMET prediction of some novel β-Amino alcohol grafted 1,4,5-trisubstituted 1,2,3-triazoles derivatives as elevators of p53 protein levels Structure-based Drug Designing for Potential Antiviral Activity of Selected Natural Products from Ayurveda against SARS SARS-CoV-2 aerosol generation during respiratory equipment reprocessing Synthesis, biological evaluation, drug-likeness, and in silico screening of novel benzylidene-hydrazone analogues as small molecule anticancer agents In-silico investigation of curcumin drug-likeness, gene-targets and prognostic relevance of the targets in panels of human cancer cohorts Protective Effect of Kolaviron on Cyclophosphamide-Induced Cardiac Toxicity in Rats A Biflavonoid with Numerous Health Benefits Antiproliferative effects of an analog of curcumin in Hep-2 cells: Acomparative study with curcumin Transmission of SARS-CoV-2: an update of current literature Phytochemical 6-Gingerol -A promising Drug of choice for COVID-19 Orally formulated artemisinin in healthy fasting Vietnamese male subjects: a randomized, four-sequence, open-label, pharmacokinetic crossover study Safety and efficacy of artemisinin-piperaquine for treatment of COVID-19: an open-label, non-randomised and controlled trial Medical-scientific rationale for a randomized, placebo-controlled, Phase 2 study of trabedersen/OT-101 in COVID-19 patients with hypoxemic respiratory failure Biochemical screening for SARS-CoV-2 main protease inhibitors Mutation of Glu-166 blocks the substrate-induced dimerization of SARS coronavirus main prote-ase 10-epoxide induced locomotor and reproductive senescence and altered biochemical parameters of oxidative damage in Canton-S Drosophila melanogaster pkCSM: Predicting small-mole-cule pharmacokinetic and toxicity properties using graph-based signatures SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules In-vitro ADME studies of TUG-891, a GPR-120 inhibitor using Swiss ADME Discovery of traditional Chinese medicine derived compounds as wild type and mutant Plasmodium falciparum dihydrofolate reductase inhibitors: induced fit docking and ADME studies Competing Interests: The authors declare that they have no competing interests. Funding: This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors Authors' contributions: Conception and design of the study: OP and OF. Acquisition of data, analysis and interpretation of data: OP and OF. Drafting the article, revising it critically for important intellectual content: OP and OF. Final approval of the version to be submitted: OP and OF Competing Interests: The authors declare that they have no competing interests.Funding: This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.Authors' contributions: Conception and design of the study: OP and OF. Acquisition of data, analysis and interpretation of data: OP and OF. Drafting the article, revising it critically for important intellectual content: OP and OF. Final approval of the version to be submitted: OP and OF.Acknowledgements: Not applicable The following information is required for submission. Please note that failure to respond to these questions/statements will mean your submission will be returned. If you have nothing to declare in any of these categories then this should be stated.Please state any sources of funding for your research All sources of funding should be declared as an acknowledgement at the end of the text. Authors should declare the role of study sponsors, if any, in the collection, analysis and interpretation of data; in the writing of the manuscript; and in the decision to submit the manuscript for publication. If the study sponsors had no such involvement, the authors should so state. Studies on patients or volunteers require ethics committee approval and fully informed written consent which should be documented in the paper.Authors must obtain written and signed consent to publish the case report from the patient (or, where applicable, the patient's guardian or next of kin) prior to submission. We ask Authors to confirm as part of the submission process that such consent has been obtained, and the manuscript must include a statement to this effect in a consent section at the end of the manuscript, as follows: "Written informed consent was obtained from the patient for publication of this case report and accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal on request".Patients have a right to privacy. Patients' and volunteers' names, initials, or hospital numbers should not be used. Images of patients or volunteers should not be used unless the information is essential for scientific purposes and explicit permission has been given as part of the consent. If such consent is made subject to any conditions, the Editor in Chief must be made aware of all such conditions. Even where consent has been given, identifying details should be omitted if they are not essential. If identifying characteristics are altered to protect anonymity, such as in genetic pedigrees, authors should provide assurance that alterations do not distort scientific meaning and editors should so note. Please specify the contribution of each author to the paper, e.g. study design, data collections, data analysis, writing, others, who have contributed in other ways should be listed as contributors.This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.Not applicable J o u r n a l P r e -p r o o f Conception and design of the study: OP and OF. Acquisition of data, analysis and interpretation of data: OP and OF. Drafting the article, revising it critically for important intellectual content: OP and OF. Final approval of the version to be submitted: OP and OF.